The effect of attention-deficit/hyperactivity disorder (ADHD) on driving behavior and risk perception.


Journal

Traffic injury prevention
ISSN: 1538-957X
Titre abrégé: Traffic Inj Prev
Pays: England
ID NLM: 101144385

Informations de publication

Date de publication:
2021
Historique:
pubmed: 27 1 2021
medline: 29 6 2021
entrez: 26 1 2021
Statut: ppublish

Résumé

To examine the effect of attention-deficit/hyperactivity disorder (ADHD) on differences in driving behavior and risk perception, in experienced drivers. A total of 147 experienced drivers participated in the study. Drivers with ADHD ( No differences in the simulator driving test were found between the ADHD group and the control group. No adverse effects of ADHD were found for any of the measures, i.e., collisions, number of speeding, risk index, speed adaptation, mean speed and preferred speed. The only significant group difference was that drivers with ADHD rated themselves lower on concentration. Participants with ADHD and the control group drove remarkably similarly in the simulator driving test and rated themselves similarly regarding how they drive. The results contribute to state that ADHD drivers are less deviant than asserted by previous research.

Identifiants

pubmed: 33497288
doi: 10.1080/15389588.2020.1847282
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108-113

Auteurs

B Lidestam (B)

Driver and Vehicle, Swedish National Transport Research Institute, Linköping, Sweden.

H Selander (H)

Driver and Vehicle, Swedish National Transport Research Institute, Linköping, Sweden.
Institute of Neuroscience and Physiology, Rehabilitation Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

T Vaa (T)

Department of Safety and Security, Institute of Transport Economics, Oslo, Norway.

B Thorslund (B)

Driver and Vehicle, Swedish National Transport Research Institute, Linköping, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH